Search

We have developed a Bayesian Maximum Entropy (BME) framework that integrates observations from a surface monitoring network and predictions from a Chemical Transport Model (CTM) to create improved exposure estimates that can be resolved into any spatial and temporal resolution. The flexibility of the framework allows for input of data in any choice of time scales and CTM predictions of any spatial resolution with varying associated degrees of estimation error and cost in terms of implementation and computation. This study quantifies the impact on exposure estimation error due to these choices by first comparing estimations errors when BME relied on ozone concentration data either as an hourly average, the daily maximum 8-h average (DM8A), or the daily 24-h average (D24A). Our analysis found that the use of DM8A and D24A data, although less computationally intensive, reduced estimation error more when compared to the use of hourly data. This was primarily due to the poorer CTM model performance in the hourly average predicted ozone. Our second analysis compared spatial variability and estimation errors when BME relied on CTM predictions with a grid cell resolution of 12 × 12 km2 versus a coarser resolution of 36 × 36 km2. Our analysis found that integrating the finer grid resolution CTM predictions not only reduced estimation error, but also increased the spatial variability in daily ozone estimates by 5 times. This improvement was due to the improved spatial gradients and model performance found in the finer resolved CTM simulation. The integration of observational and model predictions that is permitted in a BME framework continues to be a powerful approach for improving exposure estimates of ambient air pollution. The results of this analysis demonstrate the importance of also understanding model performance variability and its implications on exposure error.

Background: Food allergy is an abnormal immunological response following exposure (usually ingestion) to a food. Elimination of the allergen is the principle treatment for food allergy, including allergy to fruit. Accidental ingestion of allergenic foods can result in severe anaphylactic reactions. Allergen-specific immunotherapy (SIT) is a specific treatment, when the avoidance of allergenic foods is problematic. Recently, studies have been conducted on different types of immunotherapy for the treatment of food allergy, including oral (OIT) and sublingual immunotherapy (SLIT). Objectives: To determine the efficacy and safety of oral and sublingual immunotherapy in children and adults with food allergy to fruits, when compared with placebo or an elimination strategy. Search methods: The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, and AMED were searched for published results along with trial registries and the Journal of Negative Results in BioMedicine for grey literature. The date of the most recent search was July 2015. Selection criteria: Randomised controlled trials (RCTs) comparing OIT or SLIT with placebo or an elimination diet were included. Participants were children or adults diagnosed with food allergy who presented immediate fruit reactions. Data collection and analysis: We used standard methodological procedures expected by the Cochrane Collaboration. We assessed treatment effect through risk ratios (RRs) for dichotomous outcomes. Main results: We identified two RCTs (N=89) eligible for inclusion. These RCTs addressed oral or sublingual immunotherapy, both in adults, with an allergy to apple or peach respectively. Both studies enrolled a small number of participants and used different methods to provide these differing types of immunotherapy. Both studies were judged to be at high risk of bias in at least one domain. Overall, the quality of evidence was judged to be very low due to the small number of studies and participants and possible bias. The studies were clinically heterogeneous and hence we did not pool the results. A study comparing SLIT with placebo for allergy to peach did not detect a significant difference between the number of patients desensitised at six months following a double-blind placebo-controlled food challenge (RR 1.16, 95% confidence interval (CI) 0.49 to 2.74). The second study, comparing OIT versus no treatment for apple allergy, found an effect on desensitisation in favour of the intervention using an oral provocation test at eight months, but results were imprecise (RR 17.50, 95% CI 1.13 to 270.19). Neither study reported data on evidence of immunologic tolerance. In both studies, the incidence of mild and moderate adverse events was higher in the intervention groups than in the controls. In the study comparing SLIT with placebo, patients in the intervention group experienced significantly more local adverse reactions than participants in the control group (RR 3.21, 95% CI 1.51 to 6.82), though there was not a significant difference in the number of participants experiencing systemic adverse reactions (RR 0.81, 95% CI 0.22 to 3.02). In the study of OIT, two of the 25 participants in the intervention group reported relevant side effects, whereas no participants in the control group reported relevant side effects. Authors' conclusions: There is insufficient evidence for using OIT or SLIT to treat allergy to fruit, specifically related to peach and apple. Mild or moderate adverse reactions were reported more frequently in people receiving OIT or SLIT. However, these reactions could be treated successfully with medications. © 2015 The Cochrane Collaboration.

10.1371/journal.pone.0110207 Background Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes and to compare the risk factors identified with those associated with incident screen-detected cancers. Methods We analyzed data from 645,764 women participating in the Spanish breast cancer screening program from 2000¿2006 and followed-up until 2009. A total of 5,309 screen-detected and 1,653 interval cancers were diagnosed. Among the latter, 1,012 could be classified on the basis of findings in screening and diagnostic mammograms, consisting of 489 true interval cancers (48.2%), 235 false-negatives (23.2%), 172 minimal-signs (17.2%) and 114 occult tumors (11.3%). Information on the screening protocol and women's characteristics were obtained from the screening program registry. Cause-specific Cox regression models were used to estimate the hazard ratios (HR) of risks factors for interval cancer and incident screen-detected cancer. A multinomial regression model, using screen-detected tumors as a reference group, was used to assess the effect of breast density and other factors on the occurrence of interval cancer subtypes. Results A previous false-positive was the main risk factor for interval cancer (HR = 2.71, 95%CI: 2.28¿3.23); this risk was higher for false-negatives (HR = 8.79, 95%CI: 6.24¿12.40) than for true interval cancer (HR = 2.26, 95%CI: 1.59¿3.21). A family history of breast cancer was associated with true intervals (HR = 2.11, 95%CI: 1.60¿2.78), previous benign biopsy with a false-negatives (HR = 1.83, 95%CI: 1.23¿2.71). High breast density was mainly associated with occult tumors (RRR = 4.92, 95%CI: 2.58¿

El retraso en el diagnóstico de la infección por el VIH es frecuente en nuestro medio y se asocia a un mayor riesgo de progresión, a una menor recuperación inmunológica, mayor toxicidad y mayor probabilidad de transmisión. En este estudio revisamos el impacto de las diferentes definiciones, el impacto en términos de mortalidad y morbilidad, los factores asociados ylas implicaciones económicas. Así como las estrategias para incrementar el diagnóstico. Late presentation of HIV is common. It has been associated with greater risk of AIDS, death, lower immunological response, greater toxicity and a higher probability of transmission. In this study we review the impact of different definitions in terms of mortality and morbidity, associated factors, economic implications, as well as strategies for increasing diagnosis.

A uniqueness result for the recovery of the electric and magnetic coefficients in the time-harmonic Maxwell equations from local boundary measurements is proven. No special geometrical condition is imposed on the inaccessible part of the boundary of the domain, apart from imposing that the boundary of the domain is C1,1. The coefficients are assumed to coincide on a neighbourhood of the boundary, a natural property in applications.

Unknown

Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here, we demonstrate in a murine prostate cancer model, that high-fat diet (HFD) enhances the MYC transcriptional program through metabolic alterations that favour histone H4K20 hypomethylation at the promoter regions of MYC regulated genes, leading to increased cellular proliferation and tumour burden. Saturated fat intake (SFI) is also associated with an enhanced MYC transcriptional signature in prostate cancer patients. The SFI-induced MYC signature independently predicts prostate cancer progression and death. Finally, switching from a high-fat to a low-fat diet, attenuates the MYC transcriptional program in mice. Our findings suggest that in primary prostate cancer, dietary SFI contributes to tumour progression by mimicking MYC over expression, setting the stage for therapeutic approaches involving changes to the diet.